Novel Nicotine Delivery Systems and Public Health: The Rise of the "E-Cigarette"


2011年01月31日(Mon) 17:37


December 2010, Vol 100, No. 12 | American Journal of Public Health 2340-2342
© 2010 American Public Health Association
DOI: 10.2105/AJPH.2010.199281

Novel Nicotine Delivery Systems and Public Health: The Rise of the "E-Cigarette"

Nathan K. Cobb, MD, M. Justin Byron, MHS, David B. Abrams, PhD and Peter G. Shields, MD

Nathan K. Cobb, M. Justin Byron, and David B. Abrams are with the Schroeder Institute for
Tobacco Research and Policy Studies, Legacy Foundation, Washington, DC, and the Department
of Health, Behavior, and Society, the Johns Hopkins Bloomberg School of Public Health,
Baltimore, MD. Nathan K. Cobb and Peter G. Shields are with the Lombardi Comprehensive
Cancer Center, Georgetown University School of Medicine, Washington, DC.

Inhalation of smoke from burning tobacco remains the most deadly risky behavior in the United
States. For years, corporations have sought alternative methods to administer nicotine to
the brain without the harms of combustion while retaining the immediate rewarding aspects
of cigarettes that make them so profitable, pleasurable, and addictive. The latest attempt
at reduced harm products is a heterogeneous collection of battery-driven inhalers termed
by the World Health Organization (WHO) as electronic nicotine delivery systems (ENDS)1
or more popularly as electronic cigarettes or e-cigarettes. These devices pose significant
challenges to the public health community because their distribution and use . . .